The Precision Peptide Company Inc.
BPC
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.35M | -4.15M | -3.26M | -1.16M | -765.60K |
| Total Depreciation and Amortization | 66.00K | 66.00K | 66.00K | 34.80K | 1.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.23M | 2.19M | 1.62M | 3.30K | 60.30K |
| Change in Net Operating Assets | -154.90K | -70.30K | -95.50K | 431.00K | 47.80K |
| Cash from Operations | -2.20M | -1.97M | -1.67M | -691.20K | -656.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -198.40K | -308.70K | -361.10K | -651.10K | -161.50K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 167.10K | 167.10K | 167.10K | 167.10K | -- |
| Cash from Investing | -31.30K | -141.60K | -194.00K | -484.00K | -161.50K |
| Total Debt Issued | 100.00K | 96.60K | 100.00K | 17.80K | 17.80K |
| Total Debt Repaid | -100.90K | -117.80K | -117.80K | -100.00K | -16.90K |
| Issuance of Common Stock | 3.56M | 3.01M | 3.24M | 3.54M | 1.30M |
| Repurchase of Common Stock | -2.53M | -2.53M | -2.53M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.72M | 2.72M | 2.72M | -- | -- |
| Cash from Financing | 2.73M | 2.29M | 2.45M | 2.49M | 924.50K |
| Foreign Exchange rate Adjustments | -33.10K | -28.20K | 11.40K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 14.90K | 0.00 |
| Net Change in Cash | 459.70K | 150.30K | 603.00K | 1.33M | 106.70K |